Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals (ASX: 1AI) is a capital-light pharmaceutical company operating AlgoraeRx, a commercial division sourcing and supplying generic and specialty medicines in Australia and New Zealand through Tier-1 global manufacturer agreements, and AlgoraeOS, an AI-enabled drug discovery platform validated at Peter MacCallum Cancer Centre. The Company is focused on near-term revenue…More through executed supply agreements and long-term pipeline value through its proprietary discovery engine.